Market Overview

Life Science Executives and Investors Connect with Biotech Startups at BioPharm America™ Global Partnering Event this September

Share:

The eleventh annual BioPharm
America™
will welcome over 700 global life science executives
including pharma, established biotech, startups, and more investors than
ever seeking strategic opportunities for new deals advancing drug
development partnerships. As part of Biotech
Week Boston
, the event is produced by EBD Group and will take place
September 5–6 at the Hynes Convention Center in Boston.

"Each year, BioPharm America draws industry leaders from around the
world to this unique partnering event that forms the nexus of discovery
and realization," said Anna Chrisman, Group Managing Director, EBD
Group
. "The event plays a vital role in connecting emerging biotech
with companies that seek to work with them, facilitating partnerships
that drive growth and innovation."

The event provides robust opportunities for biotech
startups
to meet industry experts and network with investors
including one-to-one partnering, presentation
opportunities
, and startup
pitch competition
.

Hear top experts in the industry during the new Xcelerate keynote
series, including biotech pioneer Robert
Langer from MIT
; Amy
Shulman
, CEO at Lyndra and Partner at Polaris Partners; US
Surgeon General Jerome Adams
; and Elizabeth
Nabel
, President at Brigham Health.

Luke Timmerman, Founder of Timmerman Report, will give a special lunch presentation
for attendees on September 5 with amazing slides of his Mt. Everest
climb—he summited and raised $339,000 for cancer research at Fred
Hutch
in the process. Luke describes the climb's lessons about
leadership here.

Highlights of the panels with key industry leaders, pharma executives,
and investors include:

  • "How pharma and VC collaborations are changing the industry," with
    speakers from Pfizer, Medicxi, Agent Capital, and Roche Partnering.
  • "Company creation: Does in-house formation outweigh traditional
    investments for VCs?," keynote session with speakers from Lightstone
    Venture and Atlas Venture.
  • "High-impact ideas and use-inspired research, a chat on how to create
    innovations that matter," keynote session with speakers from MIT and
    Polaris Partners.
  • Xcelerate keynotes on how the life sciences is adapting to
    unprecedented changes in drug development and what is on the horizon
    with speakers from US Department of Health and Human Services, Third
    Rock Ventures, MIT, Brigham Health, and Regeneron Pharmaceuticals.
  • Panels and presentations on key therapeutic areas such as
    neurodegeneration, cell and gene therapies, rare diseases, underserved
    diseases, and oncology, with speakers from Merck, Biogen, Takeda,
    AbbVie, Novartis, Labiotech, PureTech Health, Clearview Healthcare
    Partners, Burrage Capital, MPM Capital, Oncology Impact Fun, and
    Nanobiotix USA.

In addition, this year, BioPharm America will host two pre-event
educational courses on September 4: Cell
& Gene Connect: Partnering Workshop
, featuring panel discussions
on the evolving landscape and best practices for collaboration, as well
as Product
Valuation and Deal Structuring: Business Development Masterclass
,
which will provide attendees the opportunity to review valuation
methods, refresh assessing skills, and improve both buying and selling
negotiation strategies.

EBD Group's gold-standard partneringONE®
has just been upgraded to an even more robust and powerful experience,
with enhanced search capabilities, access to attendees' meeting profiles
from all past EBD events, and a fully responsive mobile platform.
Partnering opened July 25.

Event
registration
, partneringONE®
login
, and program information are available on the BioPharm
America event web page
.

Additional links and information:

Follow BioPharm
America™
on Twitter: @EBDGroup
(hashtag: #BioPharmUSA).

About EBD Group

EBD Group's overriding mission is to help collaborations get started
across the life science value chain. Our range of partnering conferences
has grown to become the largest and most productive conference platform
in the industry. Each one of our six landmark events held in key life
science markets around the world is powered by our state-of-the-art
partnering software, partneringONE®,
that enables delegates to efficiently identify and engage with new
opportunities via one-to-one meetings.

Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™,
Biotech Showcase™, ChinaBio® Partnering Forum, Cell & Gene Connect,
Digital Medicine & Medtech Showcase, and BioEquity Europe) annually
attract more than 15,000 senior life science executives who engage in
over 50,000 one-to-one partnering meetings. These vital one-to-one
engagements are the wellspring of deals that drive innovation in our
industry.

Tune into EBD Group's Partnering
Insight
for timely coverage of news that influences the business
strategies of the life science industry. EBD Group is an Informa
company. For more information please visit www.ebdgroup.com.

View Comments and Join the Discussion!